FDA Approves Zoryve for Atopic Dermatitis

THURSDAY, July 11, 2024-- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) cream, 0.15 percent, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).Zoryve is a...